Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

33%

1 of 3 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

N/A
4(100.0%)
4Total
N/A(4)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT03216382Not ApplicableCompleted

The Impact of the Attention Training Technique on Attention Control and High Worry

Role: collaborator

NCT03855488Not ApplicableSuspended

Imagery Enhanced Cognitive Bias Modification for Chronic Worry

Role: collaborator

NCT01168128Not ApplicableCompleted

PERFormance Enhancement of the Canadian Nutrition Guidelines by a Tailored Implementation Strategy: The PERFECTIS Study

Role: collaborator

NCT03654625Not ApplicableUnknown

Development of a Scientifically Informed Written Exposure Procedure (The SCRIPTS Study)

Role: collaborator

NCT00512109Completed

Vascular Events In Noncardiac Surgery Patients Cohort Evaluation Study (VISION)

Role: collaborator

All 5 trials loaded